155 related articles for article (PubMed ID: 21590632)
21. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
22. [Paths and goals of diabetes therapy in 1984].
Mehnert H
Dtsch Med Wochenschr; 1984 Jun; 109(23):916-22. PubMed ID: 6378568
[No Abstract] [Full Text] [Related]
23. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell.
Robertson RP; Harmon JS
Free Radic Biol Med; 2006 Jul; 41(2):177-84. PubMed ID: 16814095
[TBL] [Abstract][Full Text] [Related]
24. Back to basics. Types of diabetes.
Roberts SS
Diabetes Forecast; 2005 Apr; 58(4):43-5. PubMed ID: 15858898
[No Abstract] [Full Text] [Related]
25. Beta blocker.
Davenport RJ
Sci Aging Knowledge Environ; 2005 Mar; 2005(12):nf22. PubMed ID: 15788791
[No Abstract] [Full Text] [Related]
26. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
Dagogo-Jack S; Santiago JV
Arch Intern Med; 1997 Sep; 157(16):1802-17. PubMed ID: 9290539
[TBL] [Abstract][Full Text] [Related]
27. Restoring a functional beta-cell mass in diabetes.
Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
McDonnell ME
J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
[TBL] [Abstract][Full Text] [Related]
29. [Immunotherapy for type 1 diabetes mellitus (DM1)].
van der Torren CR; Roep BO
Ned Tijdschr Geneeskd; 2012; 156(15):A4268. PubMed ID: 22495007
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenesis of type 1 and type 2 diabetes in 2011--the unifying model of glucoregulation disorder].
Skrha J
Vnitr Lek; 2011 Nov; 57(11):949-53. PubMed ID: 22165702
[TBL] [Abstract][Full Text] [Related]
31. Glycaemic variability and pancreatic β-cell dysfunction.
Kohnert KD; Freyse EJ; Salzsieder E
Curr Diabetes Rev; 2012 Sep; 8(5):345-54. PubMed ID: 22698079
[TBL] [Abstract][Full Text] [Related]
32. CXCL10- a path to β-cell death.
Paroni F; Domsgen E; Maedler K
Islets; 2009; 1(3):256-9. PubMed ID: 21099280
[TBL] [Abstract][Full Text] [Related]
33. New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Acta Clin Belg; 2006; 61(5):275-85. PubMed ID: 17240745
[TBL] [Abstract][Full Text] [Related]
34. Easing the transition to insulin therapy in people with type 2 diabetes.
Blonde L
Diabetes Educ; 2007; 33 Suppl 7():232S-240S. PubMed ID: 17656739
[No Abstract] [Full Text] [Related]
35. β-cell replenishment: Possible curative approaches for diabetes mellitus.
Rathwa N; Patel R; Palit SP; Parmar N; Rana S; Ansari MI; Ramachandran AV; Begum R
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1870-1881. PubMed ID: 32994121
[TBL] [Abstract][Full Text] [Related]
36. Beta-Cell Function and Its Underlying Mechanism 2015.
Li Y; Wang C; Omar B; Chen L
J Diabetes Res; 2016; 2016():7638120. PubMed ID: 26783538
[No Abstract] [Full Text] [Related]
37. Preservation of beta cell function.
Sperling MA
Pediatr Diabetes; 2010 May; 11(3):152-3. PubMed ID: 20546532
[No Abstract] [Full Text] [Related]
38. Pushing for a cure. What will it really take to end diabetes?
Gebel E
Diabetes Forecast; 2011 Sep; 64(9):38-43. PubMed ID: 21957652
[No Abstract] [Full Text] [Related]
39. Medical cure and progress: the case of type-1 diabetes.
Marcum JA
Perspect Biol Med; 2011; 54(2):176-88. PubMed ID: 21532132
[TBL] [Abstract][Full Text] [Related]
40. The effect of physical exercise on the dynamics of glucose and insulin.
Derouich M; Boutayeb A
J Biomech; 2002 Jul; 35(7):911-7. PubMed ID: 12052393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
